Catalyst Pharmaceuticals, Inc. financial data

Symbol
CPRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
355 Alhambra Circle, Suite 801, Coral Gables, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
Catalyst Pharmaceutical Partners, Inc. (to 5/12/2015), CATALYST PHARMACEUTICAL PARTNERS, INC. (to 5/12/2015)
Latest financial report
10-K - Q4 2024 - Feb 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 513 % +46.5%
Quick Ratio 19.5 % +3.51%
Debt-to-equity 16.3 % -18.4%
Return On Equity 25.6 % +29.7%
Return On Assets 22 % +33.8%
Operating Margin 39.7 % +82%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 121M shares +3.04%
Common Stock, Shares, Outstanding 121M shares +12.8%
Entity Public Float 1.72B USD +28.3%
Common Stock, Value, Issued 121K USD +13.1%
Weighted Average Number of Shares Outstanding, Basic 118M shares +11.5%
Weighted Average Number of Shares Outstanding, Diluted 125M shares +9.84%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 492M USD +23.5%
Research and Development Expense 12.6M USD -86.4%
Operating Income (Loss) 195M USD +125%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 216M USD +129%
Income Tax Expense (Benefit) 52.4M USD +127%
Net Income (Loss) Attributable to Parent 164M USD +130%
Earnings Per Share, Basic 1.38 USD/shares +106%
Earnings Per Share, Diluted 1.31 USD/shares +108%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 518M USD +276%
Accounts Receivable, after Allowance for Credit Loss, Current 65.5M USD +22.4%
Inventory, Net 19.5M USD +24.9%
Assets, Current 624M USD +184%
Deferred Income Tax Assets, Net 46M USD +25.8%
Property, Plant and Equipment, Net 1.35M USD +13.3%
Operating Lease, Right-of-Use Asset 2.23M USD -11.1%
Assets 851M USD +81.1%
Accounts Payable, Current 16.6M USD +12.2%
Employee-related Liabilities, Current 10.7M USD +21%
Accrued Liabilities, Current 104M USD +69.9%
Liabilities, Current 121M USD +58.7%
Operating Lease, Liability, Noncurrent 2.79M USD -12.6%
Other Liabilities, Noncurrent 315K USD -89.4%
Liabilities 124M USD +50.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax 64K USD +357%
Retained Earnings (Accumulated Deficit) 285M USD +135%
Stockholders' Equity Attributable to Parent 728M USD +87.6%
Liabilities and Equity 851M USD +81.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 31.9M USD +164%
Net Cash Provided by (Used in) Financing Activities 141M USD +94564%
Net Cash Provided by (Used in) Investing Activities -199K USD +99.9%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 121M shares +12.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 518M USD +276%
Interest Paid, Excluding Capitalized Interest, Operating Activities 65K USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 49.1M USD +28%
Operating Lease, Liability 3.19M USD -10.4%
Depreciation 86K USD +24.6%
Payments to Acquire Property, Plant, and Equipment 199K USD +169%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 164M USD +130%
Lessee, Operating Lease, Liability, to be Paid 3.69M USD -12.4%
Operating Lease, Liability, Current 402K USD +8.94%
Lessee, Operating Lease, Liability, to be Paid, Year Two 553K USD +2.98%
Lessee, Operating Lease, Liability, to be Paid, Year One 537K USD +2.87%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 499K USD -23.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 570K USD +3.07%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 587K USD +2.98%
Operating Lease, Payments 129K USD +3.2%
Additional Paid in Capital 442M USD +66%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 9.34M USD +43.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%